GRIP Molecular Technologies (GRIP) and Molecular Testing Labs (MTL) collaborated on a successful clinical feasibility study of a state-of-the-art electronic biosensor platform that aims to quickly bring lab-quality, multi-disease diagnostic testing results directly into the hands of consumers.
Using self-collected samples, GRIP’s disposable diagnostic cartridge uses a standard smartphone to display the test results and transmit them to the user’s clinician to enable data-informed telehealth interaction, rapid disease diagnosis, and the prompt application of appropriate therapy, virtually, the companies say.
“Using MTL’s highly characterized infected patient nasal swab samples, we have bolstered prior evidence of the GRIP technology’s extraordinary performance capabilities, with combined levels of diagnostic speed, convenience, and accuracy not possible with alternative technologies available for home use,” says Bruce Batten, PhD, GRIP’s founder and chief technology officer. “Evidence shows the prompt application of appropriate therapy is important to maximize its beneficial impact—and typically this is within 48 hours of symptom onset when many home-based diagnostics provide concerningly low levels of accuracy, leading to diagnosis delays. GRIP’s technology will alter this paradigm by providing robust multi-disease diagnostic information at the time and location of need, which is often in the home at the time of symptom onset when rapid access to a clinic’s diagnostic equipment may not be possible.”
GRIP says it is actively raising investment funding to support development efforts.
“Our collaboration with GRIP is a testament to our shared commitment to empower consumers by providing them ready access to their health information,” says MTL Co-Founder and Chief Innovation Officer Adam Blackwell. “Together, we are committed to developing and offering new technologies that improve health, enhance healthcare experiences, and reduce costs in ways not possible with currently commercialized technologies.”
Further reading: At-Home Testing Program Extends Nationwide
